Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

Hypertension
Ryuichi MorishitaToshio Ogihara

Abstract

Therapeutic angiogenesis using angiogenic growth factors is expected to be a new treatment for patients with critical limb ischemia (CLI). Because hepatocyte growth factor (HGF) has potent angiogenic activity, we investigated the safety and efficiency of HGF plasmid DNA in patients with CLI as a prospective open-labeled clinical trial. Intramuscular injection of naked HGF plasmid DNA was performed in ischemic limbs of 6 CLI patients with arteriosclerosis obliterans (n=3) or Buerger disease (n=3) graded as Fontaine III or IV. The primary end points were safety and improvement of ischemic symptoms at 12 weeks after transfection. Severe complications and adverse effects caused by gene transfer were not detected in any patients. Of particular importance, no apparent edema was observed in any patient throughout the trial. In addition, serum HGF concentration was not changed throughout the therapy period in all patients. In contrast, a reduction of pain scale of more than 1 cm in visual analog pain scale was observed in 5 of 6 patients. Increase in ankle pressure index more than 0.1 was observed in 5 of 5 patients. The long diameter of 8 of 11 ischemic ulcers in 4 patients was reduced >25%. Intramuscular injection of naked HGF plasmi...Continue Reading

References

Jul 1, 1991·Circulation·V Ralevic, G Burnstock
Jan 24, 1998·Biochemical and Biophysical Research Communications·S NakamuraT Ogihara
Jul 15, 1999·The Journal of Clinical Endocrinology and Metabolism·Y YoshitomiM Kuramochi
Feb 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hiromi KoikeYasufumi Kaneda

❮ Previous
Next ❯

Citations

Dec 5, 2008·Pflügers Archiv : European journal of physiology·Holger ScholzNicole Wagner
Nov 18, 2008·Journal of Anesthesia·Naomi ItoYasuhiko Tabata
Apr 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sigrid NikolUNKNOWN TALISMAN 201 investigators
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Sorin V Pislaru, Robert D Simari
Aug 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anna BaoutinaKerry R Emslie
Dec 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunyoung KimYasufumi Kaneda
Jul 12, 2011·Cardiovascular Research·Paul D Williams, Paul A Kingston
Jul 11, 2006·Current Opinion in Pulmonary Medicine·Steven E MutsaersY C Gary Lee
Jun 23, 2006·Clinical and Experimental Pharmacology & Physiology·Makoto NagasakaYasufumi Sato
Jan 14, 2011·Journal of Gastroenterology and Hepatology·Takahiro NakamuraKunio Matsumoto
Oct 5, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ognoon MungunsukhRegina M Day
Oct 10, 2009·Circulation Research·Rajesh GuptaDouglas W Losordo
Apr 13, 2012·Vascular Medicine·Geoffrey O OumaEmile R Mohler
Feb 3, 2005·Biological & Pharmaceutical Bulletin·Makiya Nishikawa
Jun 13, 2012·Biological & Pharmaceutical Bulletin·Hirotaka MiyamotoKoyo Nishida
Aug 29, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Keiichi HiroseMasashi Komeda
Dec 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuki NonakaTakahito Kondo
Jul 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yutaka SaitoTsutomu Imaizumi
Jun 17, 2010·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Toshikazu Nakamura, Shinya Mizuno
May 1, 2007·Regenerative Medicine·Shinya Mizuno, Toshikazu Nakamura
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·F SousaJ A Queiroz
Sep 2, 2011·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Hiroki YokomuroMitsumasa Okada
Jul 18, 2012·Proceedings of the American Thoracic Society·Bruno CrestaniMonique Dehoux
Nov 14, 2013·BioMed Research International·Yukihiro SaitoRyuichi Morishita
Dec 19, 2013·BioMed Research International·Hiroshi Suzuki, Yoshitaka Iso
Sep 25, 2014·The Journal of Surgical Research·Muholan KanapathyAlexander M Seifalian
Feb 18, 2011·Cellular and Molecular Life Sciences : CMLS·V Sala, T Crepaldi
May 14, 2005·Expert Review of Cardiovascular Therapy·Hironori NakagamiRyuichi Morishita
Apr 17, 2013·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·D SmadjaB I Lévy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.